Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) [Phase 2]
Phase 2 Imperial College London study evaluating dual mTORC1/2 inhibition in advanced or recurrent epithelial ovarian, fallopian tube, or pr…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. [Phase 1]
Phase I study of Cantrixil in ovarian, fallopian tube, and primary peritoneal cancers has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]
Phase 1 study shows safety, pharmacokinetics and preliminary anti-tumor activity of RP12146 in patients with solid tumors, including extensi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating NY-ESO-1 TCR-engineered T cells with hematopoietic stem cells after melphalan conditioning in recurrent or refrac…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
This Clinical Trial Update documents the establishment and standardization of a platform for in-depth tumor profiling (TUPRO-Gyn) in patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: "Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial evaluating re-stimulated tumor-infiltrating lymphocytes (TILs) with interleukin-2 for platinum-resistant recurrent ca…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluated pembrolizumab in combination with carboplatin and paclitaxel for Stage III–IV ovarian, primary peritoneal, or fall…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer [Phase 2]
Phase 2 trial of HS-20089 for ovarian cancer, fallopian tube cancer, primary peritoneal cancer, and endometrial cancer is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial of a cancer vaccine therapy combined with cyclophosphamide for patients with Stage II-III breast cancer or Stage II-IV ovarian…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy [NA]
The document reports a clinical trial evaluating quadratus lumborum block for postoperative pain management after cytoreductive surgery with…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients [Phase 1]
Phase 1 trial update on intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in patients with recurrent ovarian cancer, recurren…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression [Phase 3]
A Phase 3 study of mirvetuximab soravtansine in platinum-resistant, high-FRα epithelial ovarian, primary peritoneal, or fallopian tube cance…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression [Phase 3]
Phase 3 trial comparing mirvetuximab soravtansine with investigator's choice chemotherapy in FRα-high, platinum-resistant epithelial ovarian…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Study of PF-06873600 in People With Cancer [Phase 1, Phase 2]
Pfizer's PF-06873600 in Phase 1/2 for several cancers was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers [Phase 1]
Phase 1 clinical trial evaluating nab-paclitaxel in combination with bevacizumab in patients with unresectable stage IV melanoma or gynecolo…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer [Phase 1]
This Phase 1 trial update reports completion of a study evaluating weekly paclitaxel with oncothermia and weekly cisplatin with oncothermia …
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Phase 2]
Phase 2 clinical trial evaluating a dendritic cell/tumor fusion vaccine with GM-CSF and Imiquimod for ovarian cancer, primary peritoneal can…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
A clinical trial is evaluating capillary home-sampling combined with a protein biomarker test for early detection of relapse in ovarian canc…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating neo-adjuvant pembrolizumab in primary stage IV ovarian cancer with peritoneal or fallopian tube involvement. The …
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression [Phase 2]
A Phase 2 clinical trial update for RC48 (disitamab vedotin) in platinum-sensitive recurrent ovarian cancer expressing HER2; the study is cu…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab [Phase 2]
Phase 2 trial evaluating weekly ixabepilone with or without biweekly bevacizumab in epithelial ovarian cancer and related peritoneal cancers…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer [NA]
The LCC-CARIS-01 trial focusing on molecular profiling in gynecologic cancers has completed. The study included epithelial ovarian cancer, p…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib [Phase 3]
Phase 3 rollover study CATCH-R provides continued access to rucaparib for eligible patients with metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer [Phase 1]
The Phase 1 study of KHK2866, an HB-EGF–targeting antibody, in advanced solid tumors and ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of DSP-7888 Dosing Emulsion in combination with immune checkpoint inhibitors in adults with advanced solid tumors was termin…